Cancer

Title
Comparison of Hormonal Therapies Before Surgery in Post-menopausal Women with Early Stage, Estrogen Receptor Positive Breast Cancer (ALTERNATE)
Trial Number
206253031914
Number of Participants
2,820
Principal Investigator

Kathy S. Albain

M.D.
Hematology/Oncology
Professor
Eligibility

• Patients with the following criteria may be eligible: Adult postmenopausal women with ECOG PS 0-2; clinical stage T2-T4c, any N, M0, ER+, HER2- invasive breast cancer; no prior treatment for this cancer.

Purpose

This study aims to identify patients with estrogen receptor positive tumors that don’t need chemotherapy despite the tumor being larger.

Enrollment

(708) 327-3102

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.